Skip to main content

Medical Services

A Canadian company has acquired the drug development program for a derivative of ibogaine, a potential treatment for opioid addiction.
Reports from poison control centers illustrate the medical risks associated with prescription amphetamine misuse, with administration by injection generally associated with the worst outcomes.
CODAC Behavioral Healthcare is piloting a mobile treatment unit that is bringing medical care, counseling and referral guidance to high-need communities.
A report from the American Medical Association and Manatt Health suggests that Medicaid expansion states have a significant advantage in combating the opioid epidemic.
Cannabidiol (CBD) is being touted as an elixir for pain and numerous other ills. Amid the claims, addiction treatment patients are starting to seek guidance from their clinicians.
Click here and listen to Dr. Patricia Essilfie, a physician at St. John’s Well Child, as she describes how the once limited resources and treatment plans for smokers at St. John’s, were transformed…
Back to Top